AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Pasithea Therapeutics Corp.

$0.37 -$0.82 (-68.89%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$0.37
Day Range
$0.36$0.39
Year Range
$0.28$2.06
Market Cap
12.37M
AVG Volume
558.72K
Trailing/Forward PE
-0.15/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
2026-11-12
Primary Exchange
NASDAQUS
Revenue (USD) · A
05K10K15K20K20212022202320242025
KTTA Revenue (USD) by year
PeriodRevenue (USD)
20250
20240
20230
20220
202115.06K
Net Income (USD) · A
-30M-20M-10M020212022202320242025
KTTA Net Income (USD) by year
PeriodNet Income (USD)
2025-20.43M
2024-13.9M
2023-15.96M
2022-12.32M
2021-2.17M
Operating Income (USD) · A
-30M-20M-10M020212022202320242025
KTTA Operating Income (USD) by year
PeriodOperating Income (USD)
2025-20.86M
2024-14.25M
2023-15.98M
2022-12.59M
2021-4.51M
EBITDA · A
Cash Flows · A
EPS · A
Expenses · A
Cash & Debt · A
Debt ratios · A
Margins · A
Return on Capital · A
Shares Outstanding · A
Dividends (USD) · A
Employee Count
Book Value Per Share · A
Total Assets · A
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: KTTA

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 12 Nov 2026.

Pasithea Therapeutics Corp.
KTTA
Stockpicker

Video analysis: KTTA

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: KTTA

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.